Hi everyone,
It would be great to collate some comparable sales data to this thread with regard to more recent acquisitions (or even mergers) in the cell therapy space.
Companies Involved
Date of Acquisition
Price
Country
Product
Summary
How does Mesoblast stack up globally to its peers in the cell therapy space with its advanced pipeline.
I don't know about you but its current US$500-600m enterprise value seems way under especially if they get their foot in the door with a product in the US.
Thank you in advance
Valuation, page-8
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 98.0¢ | $4.720M | 4.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 171759 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 16000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |